A citation-based method for searching scientific literature

Yingxi Li, Xiyang Li, Mei Cao, Yuke Jiang, Jie Yan, Ze Liu, Rongcun Yang, Xu Chen, Peiqing Sun, Rong Xiang, Longlong Wang, Yi Shi. Signal Transduct Target Ther 2019
Times Cited: 8







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Unique domain appended to vertebrate tRNA synthetase is essential for vascular development.
Xiaoling Xu, Yi Shi, Hui-Min Zhang, Eric C Swindell, Alan G Marshall, Min Guo, Shuji Kishi, Xiang-Lei Yang. Nat Commun 2012
69
37

tRNA synthetase counteracts c-Myc to develop functional vasculature.
Yi Shi, Xiaoling Xu, Qian Zhang, Guangsen Fu, Zhongying Mo, George S Wang, Shuji Kishi, Xiang-Lei Yang. Elife 2014
35
37

Seryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence.
Yingxi Li, Xiyang Li, Mei Cao, Yuke Jiang, Jie Yan, Ze Liu, Rongcun Yang, Xu Chen, Peiqing Sun, Rong Xiang,[...]. Signal Transduct Target Ther 2019
5
60

Circulating tumor cells and CDX models as a tool for preclinical drug development.
Alice Lallo, Maximilian W Schenk, Kristopher K Frese, Fiona Blackhall, Caroline Dive. Transl Lung Cancer Res 2017
37
25

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.
Theodora Voskoglou-Nomikos, Joseph L Pater, Lesley Seymour. Clin Cancer Res 2003
364
25


Aminoacyl-tRNA synthetases as therapeutic targets.
Nam Hoon Kwon, Paul L Fox, Sunghoon Kim. Nat Rev Drug Discov 2019
51
25

Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.
Zheng Zhou, Bao Sun, Shiqiong Huang, Dongsheng Yu, Xiaochuan Zhang. Cell Death Dis 2020
4
50

PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase.
Gommaar D'Hulst, Inés Soro-Arnaiz, Evi Masschelein, Koen Veys, Gillian Fitzgerald, Benoit Smeuninx, Sunghoon Kim, Louise Deldicque, Bert Blaauw, Peter Carmeliet,[...]. Nat Commun 2020
66
25

The tRNA-associated dysregulation in immune responses and immune diseases.
Chunsheng Zhu, Bao Sun, Anzheng Nie, Zheng Zhou. Acta Physiol (Oxf) 2020
4
50

Inhibiting DX2-p14/ARF Interaction Exerts Antitumor Effects in Lung Cancer and Delays Tumor Progression.
Ah-Young Oh, Youn Sang Jung, Jiseon Kim, Jee-Hyun Lee, Jung-Hyun Cho, Ho-Young Chun, Soyoung Park, Hyunchul Park, Sikeun Lim, Nam-Chul Ha,[...]. Cancer Res 2016
17
25


Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.
Eugenio Cavalli, Emanuela Mazzon, Santa Mammana, Maria Sofia Basile, Salvo Danilo Lombardo, Katia Mangano, Placido Bramanti, Ferdinando Nicoletti, Paolo Fagone, Maria Cristina Petralia. Brain Sci 2019
16
12

Emodin Induces Apoptotic Death in Murine Myelomonocytic Leukemia WEHI-3 Cells In Vitro and Enhances Phagocytosis in Leukemia Mice In Vivo.
Yuan-Chang Chang, Tung-Yuan Lai, Chun-Shu Yu, Hung-Yi Chen, Jai-Sing Yang, Fu-Shin Chueh, Chi-Cheng Lu, Jo-Hua Chiang, Wen-Wen Huang, Chia-Yu Ma,[...]. Evid Based Complement Alternat Med 2011
29
12

Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy.
Adriana Albini, Antonino Bruno, Douglas M Noonan, Lorenzo Mortara. Front Immunol 2018
137
12

Plants and their active compounds: natural molecules to target angiogenesis.
Kai Lu, Madhavi Bhat, Sujit Basu. Angiogenesis 2016
27
12

Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
Pierre Germain, Jaya Iyer, Christina Zechel, Hinrich Gronemeyer. Nature 2002
235
12

Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.
Mario Presti, Emanuela Mazzon, Maria Sofia Basile, Maria Cristina Petralia, Alessia Bramanti, Giuseppe Colletti, Placido Bramanti, Ferdinando Nicoletti, Paolo Fagone. Oncol Lett 2018
43
12

Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells.
Claire M Banwell, Donia P MacCartney, Michelle Guy, Alice E Miles, Milan R Uskokovic, Janine Mansi, Paul M Stewart, Laura P O'Neill, Bryan M Turner, Kay W Colston,[...]. Clin Cancer Res 2006
63
12

Antiangiogenic therapy for cancer: an update.
Belal Al-Husein, Maha Abdalla, Morgan Trepte, David L Deremer, Payaningal R Somanath. Pharmacotherapy 2012
100
12

Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.
Robert J Gillies, Daniel Verduzco, Robert A Gatenby. Nat Rev Cancer 2012
376
12

The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome.
Andrew R Green, Claire Burney, Christopher J Granger, E Claire Paish, Somaia El-Sheikh, Emad A Rakha, Desmond G Powe, R Douglas Macmillan, Ian O Ellis, Eleni Stylianou. Breast Cancer Res Treat 2008
48
12

Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Farhat L Khanim, Lyndon M Gommersall, Victoria H J Wood, Kirsty L Smith, Leire Montalvo, Laura P O'Neill, Yue Xu, Donna M Peehl, Paul M Stewart, Bryan M Turner,[...]. Oncogene 2004
98
12

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma.
Laura Soumoy, Nadège Kindt, Ghanem Ghanem, Sven Saussez, Fabrice Journe. Cancers (Basel) 2019
17
12

Role of HIF-1 in Cancer Progression: Novel Insights. A Review.
Aldo Pezzuto, Elisabetta Carico. Curr Mol Med 2018
84
12


Emodin as an effective agent in targeting cancer stem-like side population cells of gallbladder carcinoma.
Xin-xing Li, Ying Dong, Wei Wang, Hao-lu Wang, Yu-ying Chen, Gui-ying Shi, Jing Yi, Jian Wang. Stem Cells Dev 2013
42
12

Imaging key biomarkers of tumor angiogenesis.
Marina V Backer, Joseph M Backer. Theranostics 2012
56
12

Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent.
Gopal Srinivas, Suboj Babykutty, Priya Prasanna Sathiadevan, Priya Srinivas. Med Res Rev 2007
153
12

Corepressor SMRT is required to maintain Hox transcriptional memory during somitogenesis.
Suk-Hyun Hong, Sungsoon Fang, Benson C Lu, Russell Nofsinger, Yasuhiko Kawakami, Glenda L Castro, Yunqiang Yin, Chengqi Lin, Ruth T Yu, Michael Downes,[...]. Proc Natl Acad Sci U S A 2018
8
12


Emerging roles of the corepressors NCoR1 and SMRT in homeostasis.
Adrienne Mottis, Laurent Mouchiroud, Johan Auwerx. Genes Dev 2013
141
12

Co-delivery of VEGF siRNA and Etoposide for Enhanced Anti-angiogenesis and Anti-proliferation Effect via Multi-functional Nanoparticles for Orthotopic Non-Small Cell Lung Cancer Treatment.
Fang Li, Yu Wang, Wei-Liang Chen, Dan-Dan Wang, Ye-Juan Zhou, Ben-Gang You, Yang Liu, Chen-Xi Qu, Shu-di Yang, Meng-Tian Chen,[...]. Theranostics 2019
31
12

Z-Selective Cross-Metathesis and Homodimerization of 3E-1,3-Dienes: Reaction Optimization, Computational Analysis, and Synthetic Applications.
Shao-Xiong Luo, Jeffrey S Cannon, Buck L H Taylor, Keary M Engle, K N Houk, Robert H Grubbs. J Am Chem Soc 2016
12
12


6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Helena M Earl, Louise Hiller, Anne-Laure Vallier, Shrushma Loi, Karen McAdam, Luke Hughes-Davies, Adrian N Harnett, Mei-Lin Ah-See, Richard Simcock, Daniel Rea,[...]. Lancet 2019
93
12

Side effects of anti-angiogenic drugs.
Francesca Elice, Francesco Rodeghiero. Thromb Res 2012
62
12

VEGF targets the tumour cell.
Hira Lal Goel, Arthur M Mercurio. Nat Rev Cancer 2013
637
12


Aloe-emodin as drug candidate for cancer therapy.
Nadire Özenver, Mohamed Saeed, Lütfiye Ömur Demirezer, Thomas Efferth. Oncotarget 2018
22
12

Differences in pharmacokinetics and ex vivo antioxidant activity following intravenous and oral administrations of emodin to rats.
Chi-Sheng Shia, Yu-Chi Hou, Shang-Yuan Tsai, Pei-Hsun Huieh, Yann-Lii Leu, Pei-Dawn Lee Chao. J Pharm Sci 2010
45
12

Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.
Maria Sofia Basile, Emanuela Mazzon, Tamara Krajnovic, Dijana Draca, Eugenio Cavalli, Yousef Al-Abed, Placido Bramanti, Ferdinando Nicoletti, Sanja Mijatovic, Danijela Maksimovic-Ivanic. Molecules 2018
30
12

Macrophage M1/M2 polarization.
Chen Yunna, Hu Mengru, Wang Lei, Chen Weidong. Eur J Pharmacol 2020
42
12

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
Kathy Miller, Molin Wang, Julie Gralow, Maura Dickler, Melody Cobleigh, Edith A Perez, Tamara Shenkier, David Cella, Nancy E Davidson. N Engl J Med 2007
12



Macrophages Facilitate Resistance to Anti-VEGF Therapy by Altered VEGFR Expression.
Heather J Dalton, Sunila Pradeep, Michael McGuire, Yared Hailemichael, Shaolin Ma, Yasmin Lyons, Guillermo N Armaiz-Pena, Rebecca A Previs, Jean Marie Hansen, Rajesha Rupaimoole,[...]. Clin Cancer Res 2017
37
12

Metastatic and triple-negative breast cancer: challenges and treatment options.
Sumayah Al-Mahmood, Justin Sapiezynski, Olga B Garbuzenko, Tamara Minko. Drug Deliv Transl Res 2018
131
12

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.
Cornelia Liedtke, Chafika Mazouni, Kenneth R Hess, Fabrice André, Attila Tordai, Jaime A Mejia, W Fraser Symmans, Ana M Gonzalez-Angulo, Bryan Hennessy, Marjorie Green,[...]. J Clin Oncol 2008
12

Naturally occurring compounds in differentiation based therapy of cancer.
Sanja Mijatović, Alessia Bramanti, Ferdinando Nicoletti, Paolo Fagone, Goran N Kaluđerović, Danijela Maksimović-Ivanić. Biotechnol Adv 2018
16
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.